智通财经APP讯，智云健康(09955)发布公告，于2025年2月，公司作为以数字化赋能慢病管理的领导者，将DeepSeek-R1模型接入其专属医疗人工智能智云大脑，进一步增强智云大脑的数据挖掘能力并提升公司医院SaaS及药店SaaS的慢病管理效率。
智云大脑对DeepSeek-R1模型的接入，结合了先进的数据分析和人工智能技术，通过大数据分析及机器学习算法，为慢病管理提供精准的决策支持。此次接入后，借助公司超过10亿份电子病历，公司的ClouD GPT及ClouD DTx模型将实现医疗知识图谱和临床决策支持系统的功能升级，以优化用户体验并提高诊断效率。
根据中国国际广播电台经济之声联合赛迪顾问股份有限公司发布的《2024年人工智能大模型行业调查研究报告》，公司因其在市场地位和发展潜力方面的卓越表现，被评为医疗人工智能行业的市场领导者之一。智云大脑接入 DeepSeek-R1模型将巩固公司在医疗人工智能行业的领导地位，加速智云大脑在慢病管理中的应用。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.